Environmental Toxicology · 2019 · 36 citations · 20 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyCancer Stem Cell BiologyCancer Stem Cell MaintenanceCancer Stem CellsLung CancerMalignant NeoplasmsSignal Transduction In CancerCancer Stem Cell - Mediated ResistanceCancer Stem Cell-mediated ResistanceMicrorna-mediated ResistanceMyd88-dependent SignalingNon-small Cell Lung Cancer ImagingNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentStemness Regulation
Although the inhibitory roles of ursolic acid (UA) have been established in various tumors, its effects on the stemness of non-small cell lung cancer (NSCLC) cells are still unclear. Here, we constructed NSCLC cells with paclitaxel resistance (A549-PR) and showed that A549-PR exhibited a remarkably stronger stemness than the parental A549 cells, which is evident by the increase of spheroid formation capacity, stemness marker expression, and ALDH1 activity. Additionally, UA significantly reduced the stemness and paclitaxel resistance of A549-PR cells. Mechanistic investigations revealed that UA inhibited the miR-149-5p/MyD88 signaling, which is responsible for UA-mediated effects on the stemness of A549-PR cells. Notably, miR-149-5p/MyD88 axis promoted the stemness of A549 cells, while inhibition of this axis attenuated the stemness of A549-PR cells. Therefore, these results suggest that UA could attenuate the stemness and chemoresistance of NSCLC cells through targeting miR-149-5p/MyD88 axis.
20
Salinomycin kills cancer stem cells by sequestering iron in lysosomes
Trang Thi, Ahmed Hamaï, Antje Hienzsch et al. · Nature Chemistry · 2017 · 611 citations
Medicine, Cell Biology, Oncology +12
MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
Lanlan Gao, Qianqian Guo, Xiaoman Li et al. · EBioMedicine · 2019 · 168 citations · Full text
Medicine, Cancer Biology, Oncology +16
Lufeng Zheng, Chenxi Xiang, Xiaoman Li et al. · Journal of Hematology & Oncology · 2018 · 129 citations · Full text